why choose us

First received: October 24, 2023

Clinical Trial: Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Anatomic Stage 0 Breast Cancer AJCC v8

Study Type: OBSERVATIONAL


Official Title: Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS): A Multidisciplinary Pain Program Designed to Decrease Pain and Improve Functioning, Mood, and Me

Brief Summary: This study evaluates the effectiveness of a cognitive behavioral multicomponent treatment program in improving pain, mood, and functioning while reducing medication non-adherence in breast cancer patients with Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS).

Read more